Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Kristine Ramsay-Seaner, Amber Letcher, Meagan Scott Hoffman, Emily Anderson & Charlotte Heckmann. (2022) Perceptions of prescription opioid use among rural farming and ranching communities: Preliminary implications for outreach and treatment. Substance Abuse 43:1, pages 1245-1250.
Read now
Read now
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Christopher Cebollero, Neyla Darwaza, Chong Kim, Diane Ito & Josh Epstein. (2022) Real-world study of multiple naloxone administrations for opioid overdose reversal among emergency medical service providers. Substance Abuse 43:1, pages 1075-1084.
Read now
Read now
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito & Josh Epstein. (2022) The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature. Substance Abuse 43:1, pages 774-784.
Read now
Read now
Amy Bettano, Katarina Jones, Katherine T. Fillo, Ridgely Ficks & Dana Bernson. (2022) Opioid-related incident severity and emergency medical service naloxone administration by sex in Massachusetts, 2013–2019. Substance Abuse 43:1, pages 479-485.
Read now
Read now
Scott G. Weiner$suffix/text()$suffix/text(), Olesya Baker$suffix/text()$suffix/text(), Dana Bernson$suffix/text()$suffix/text() & Jeremiah D. Schuur$suffix/text()$suffix/text(). (2022) One year mortality of patients treated with naloxone for opioid overdose by emergency medical services. Substance Abuse 43:1, pages 99-103.
Read now
Read now
Ola Dale. (2022) Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 203-217.
Read now
Read now
Eleanor Rochester & Melissa Graboyes. (2022) Experiences of people who use drugs with naloxone administration: a qualitative study. Drugs: Education, Prevention and Policy 29:1, pages 54-61.
Read now
Read now
Andrew Farkas$suffix/text()$suffix/text(), Rachael Westover$suffix/text()$suffix/text(), Anthony F. Pizon$suffix/text()$suffix/text(), Michael Lynch$suffix/text()$suffix/text() & Christian Martin-Gill$suffix/text()$suffix/text(). (2021) Outcomes following Naloxone Administration by Bystanders and First Responders. Prehospital Emergency Care 25:6, pages 740-746.
Read now
Read now
James R. Langabeer, David Persse, Andrea Yatsco, Meredith M. O’Neal & Tiffany Champagne-Langabeer. (2021) A Framework for EMS Outreach for Drug Overdose Survivors: A Case Report of the Houston Emergency Opioid Engagement System. Prehospital Emergency Care 25:3, pages 441-448.
Read now
Read now
Caroline Geiger, Rosanna Smart & Bradley D. Stein. (2020) Who receives naloxone from emergency medical services? Characteristics of calls and recent trends. Substance Abuse 41:3, pages 400-407.
Read now
Read now
Sarah G. Mahonski, James B. Leonard, J. David Gatz, Hyunuk Seung, Erin E. Haas & Hong K. Kim. (2020) Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data. Clinical Toxicology 58:2, pages 117-123.
Read now
Read now
Hong K. Kim, Nicholas J. Connors & Maryann E. Mazer-Amirshahi. (2019) The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs. Expert Opinion on Drug Safety 18:6, pages 465-475.
Read now
Read now
Alice Bell, Alex S. Bennett, T. Stephen Jones, Maya Doe-Simkins & Leslie D. Williams. (2019) Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Substance Abuse 40:1, pages 52-55.
Read now
Read now
Scott A. Goldberg, Daniel A. Dworkis, Vincent T. Liao, Andrew J. Eyre, Jack Albert, Meghan M. Fawcett, Conor M. Narovec, James DiClemente & Scott G. Weiner. (2018) Feasibility of Bystander Administration of Public-Access Naloxone for Opioid Overdose. Prehospital Emergency Care 22:6, pages 788-794.
Read now
Read now
Jeremiah M. Kinsman & Kathy Robinson. (2018) National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels' Authority to Administer Opioid Antagonists. Prehospital Emergency Care 22:5, pages 650-654.
Read now
Read now
Joseph M. Grover, Taibah Alabdrabalnabi, Mehul D. Patel, Michael W. Bachman, Timothy F. Platts-Mills, Jose G. Cabanas & Jefferson G. Williams. (2018) Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System. Prehospital Emergency Care 22:3, pages 281-289.
Read now
Read now
Nazey Gulec, Joseph Lahey, James C. Suozzi, Matthew Sholl, Charles D. MacLean & Daniel L. Wolfson. (2018) Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England. Prehospital Emergency Care 22:2, pages 163-169.
Read now
Read now
Jody Morgan & Alison L Jones. (2018) The role of naloxone in the opioid crisis. Toxicology Communications 2:1, pages 15-18.
Read now
Read now
Articles from other publishers (58)
Bina Ali, Steve Shamblen, William Scarbrough, Katharine Atwood, Ua-aree Sangpukdee, Elise Andrews, Jan Markowitz & Amanda Wensel. (2023) Opioid overdose prevention training needs: Findings from emergency medical services providers in Baltimore County, Maryland. Evaluation and Program Planning 101, pages 102353.
Crossref
Crossref
Jennifer Bolster, Richard Armour, Michelle O’Toole, Meghan Lysko & Alan M. Batt. (2023) The paramedic role in caring for people who use illicit and controlled drugs: A scoping review. Paramedicine 20:4, pages 117-127.
Crossref
Crossref
Madigan L. Bedard, Alexandra C. Nowlan, Zoe Martin del Campo, Colin Miller, Nabarun Dasgupta & Zoe A. McElligott. (2023) All Hands on Deck: We Need Multiple Approaches To Uncover the Neuroscience behind the Opioid Overdose Crisis. ACS Chemical Neuroscience 14:11, pages 1921-1929.
Crossref
Crossref
Madigan L. Bedard, Julia Sparks Lord, Patric J. Perez, Isabel M. Bravo, Adonay T. Teklezghi, Lisa M. Tarantino, Graham H. Diering & Zoe A. McElligott. (2023) Probing different paradigms of morphine withdrawal on sleep behavior in male and female C57BL/6J mice. Behavioural Brain Research 448, pages 114441.
Crossref
Crossref
Kirstin Acus, Jessica Krizo, Spencer Prete, Thomas Langlois, Ashley Pajela, Caroline Mangira, Erin Simon & Amy Raubenolt. (2023) DO HIGHER DOSES OF NALOXONE INCREASE THE RISK OF PULMONARY COMPLICATIONS?. The Journal of Emergency Medicine 64:3, pages 353-358.
Crossref
Crossref
Charlotte Goldfine, Brittany Chapman, Melissa Taylor, Evan Bradley, Stephanie Carreiro, Rochelle Rosen, Kavita Babu & Jeffrey Lai. (2023) Experiences with Medications for Addiction Treatment Among Emergency Department Patients with Opioid Use Disorder. Western Journal of Emergency Medicine 24:2, pages 236-242.
Crossref
Crossref
Amanda Smith & Mary Masterson. (2023) The Approach to Altered Mental Status. Physician Assistant Clinics 8:1, pages 139-150.
Crossref
Crossref
Randa Abdelal, A. Raja Banerjee, Suzanne Carlberg-Racich, Neyla Darwaza, Diane Ito, Jessica Shoaff & Josh Epstein. (2022) Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Harm Reduction Journal 19:1.
Crossref
Crossref
Arne Kristian Skulberg, Ida Tylleskär, Morten Valberg, Anne‐Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Tore Skålhegg, Jan Barstein, Sindre Mellesmo & Ola Dale. (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial. Addiction 117:6, pages 1658-1667.
Crossref
Crossref
Phil Skolnick. (2022) Treatment of overdose in the synthetic opioid era. Pharmacology & Therapeutics 233, pages 108019.
Crossref
Crossref
Anthony M. Downs & Zoe A. McElligott. (2022) Noradrenergic circuits and signaling in substance use disorders. Neuropharmacology 208, pages 108997.
Crossref
Crossref
Lucas G. Hill, Claire M. Zagorski & Lindsey J. Loera. (2022) Increasingly powerful opioid antagonists are not necessary. International Journal of Drug Policy 99, pages 103457.
Crossref
Crossref
Sarah Davis & Jun Zhu. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status
403
441
.
Soroush Moallef, JinCheol Choi, M.-J. Milloy, Kora DeBeck, Thomas Kerr & Kanna Hayashi. (2021) A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting. Harm Reduction Journal 18:1.
Crossref
Crossref
Joseph V. PergolizziJrJr, Albert Dahan, Jo Ann LeQuang & Robert B. Raffa. (2021) Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1501-1504.
Crossref
Crossref
Rachel S. Bergstein, Kelly King, G.J. Melendez-Torres & Amanda D. Latimore. (2021) Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care. International Journal of Drug Policy 97, pages 103296.
Crossref
Crossref
Nicholas B. Miner, William E. Schutzer, Yalda Zarnegarnia, Aaron Janowsky & Randy Torralva. (2021) Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments. Drug and Alcohol Dependence 227, pages 108974.
Crossref
Crossref
John F. Peppin, Joseph V. PergolizziJr.Jr., Albert Dahan & Robert B. Raffa. (2021) Are opioid receptor antagonists adequate for “Opioid” overdose in a changing reality?. Journal of Clinical Pharmacy and Therapeutics 46:4, pages 861-866.
Crossref
Crossref
Bryce Pardo, Jirka Taylor, Jon Caulkins, Peter Reuter & Beau Kilmer. (2020) The dawn of a new synthetic opioid era: the need for innovative interventions. Addiction 116:6, pages 1304-1312.
Crossref
Crossref
Dalia Khoury, Alexander Preiss, Paul Geiger, Mohd Anwar & Kevin Paul Conway. (2021) Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study. JMIR Public Health and Surveillance 7:5, pages e29298.
Crossref
Crossref
Lauren A. Forbes, Joseph K. Canner, Lorraine Milio, Torre Halscott & Arthur Jason Vaught. (2021) Association of Patient Sex and Pregnancy Status With Naloxone Administration During Emergency Department Visits. Obstetrics & Gynecology 137:5, pages 855-863.
Crossref
Crossref
Cameron Dezfulian, Aaron M. Orkin, Bradley A. Maron, Jonathan Elmer, Saket Girotra, Mark T. Gladwin, Raina M. Merchant, Ashish R. Panchal, Sarah M. Perman, Monique Anderson Starks, Sean van Diepen & Eric J. Lavonas. (2021) Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association. Circulation 143:16.
Crossref
Crossref
Sean D. Young, Qingpeng Zhang, Jiandong Zhou & Rosalie Liccardo Pacula. (2021) Internet search and medicaid prescription drug data as predictors of opioid emergency department visits. npj Digital Medicine 4:1.
Crossref
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberWilson Compton & Christopher Jones. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Wilson M. Compton, Rita J. Valentino & Robert L. DuPont. (2020) Polysubstance use in the U.S. opioid crisis. Molecular Psychiatry 26:1, pages 41-50.
Crossref
Crossref
Stephen Parkin, Joanne Neale, Caral Brown, Jermaine D. Jones, Laura Brandt, Felipe Castillo, Aimee N.C. Campbell, John Strang & Sandra D. Comer. (2021) A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.. International Journal of Drug Policy 87, pages 102968.
Crossref
Crossref
G. Franklin EdwardsIIIIII, Cassandra Mierisch, Brock Mutcheson, Kimberly Horn & Sarah Henrickson Parker. (2020) A review of performance assessment tools for rescuer response in opioid overdose simulations and training programs. Preventive Medicine Reports 20, pages 101232.
Crossref
Crossref
Lauren M. Maloney, Timur Alptunaer, Gia Coleman, Suleiman Ismael, Peter J. McKenna, R. Trevor Marshall, Cristina Hernandez & Daryl W. Williams. (2020) Prehospital Naloxone and Emergency Department Adverse Events: A Dose-Dependent Relationship. The Journal of Emergency Medicine 59:6, pages 872-883.
Crossref
Crossref
Grant A. Victor, Justin C. Strickland, Athena Z. Kheibari & Christopher Flaherty. (2020) A mixed-methods approach to understanding overdose risk-management strategies among a nationwide convenience sample. International Journal of Drug Policy 86, pages 102973.
Crossref
Crossref
Evan M. Lowder, Spencer G. Lawson, Daniel O'Donnell, Emily Sightes & Bradley R. Ray. (2020) Two‐year outcomes following naloxone administration by police officers or emergency medical services personnel. Criminology & Public Policy 19:3, pages 1019-1040.
Crossref
Crossref
Brennon R. Luster, Elizabeth S. Cogan, Karl T. Schmidt, Dipanwita Pati, Melanie M. Pina, Kedar Dange & Zoé A. McElligott. (2019) Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal. Addiction Biology 25:3.
Crossref
Crossref
G. Anthony Fidacaro, Prarthi Patel, Gerard Carroll, Holly Bartimus, Krystal Hunter & Rick Hong. (2020) Do Patients Require Emergency Department Interventions After Prehospital Naloxone?. Journal of Addiction Medicine 14:3, pages 224-230.
Crossref
Crossref
Holly Thurston & Bridget Freisthler. (2020) The spatio-temporal distribution of naloxone administration events in rural Ohio 2010–16. Drug and Alcohol Dependence 209, pages 107950.
Crossref
Crossref
Richard J. Bodnar. (2020) Endogenous opiates and behavior: 2017. Peptides 124, pages 170223.
Crossref
Crossref
Bradley Ray, Evan Lowder, Katie Bailey, Philip Huynh, Richard Benton & Dennis Watson. (2020) Racial differences in overdose events and polydrug detection in Indianapolis, Indiana. Drug and Alcohol Dependence 206, pages 107658.
Crossref
Crossref
Gregory Janis. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory
269
276
.
Ronald B. Moss & Dennis J. Carlo. (2019) Higher doses of naloxone are needed in the synthetic opioid era. Substance Abuse Treatment, Prevention, and Policy 14:1.
Crossref
Crossref
Michael Fendrich, Jessica Becker & Jennifer Hernandez-Meier. (2019) Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study. Addictive Behaviors Reports 10, pages 100212.
Crossref
Crossref
Xinyi Gao & Nicole K. Brogden. (2019) Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus. Journal of Pharmaceutical Sciences 108:11, pages 3695-3703.
Crossref
Crossref
Elizabeth Saunders, Stephen A. Metcalf, Olivia Walsh, Sarah K. Moore, Andrea Meier, Bethany McLeman, Samantha Auty, Sarah Bessen & Lisa A. Marsch. (2019) “You can see those concentric rings going out”: Emergency personnel’s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug and Alcohol Dependence 204, pages 107555.
Crossref
Crossref
Wilson M. Compton & Christopher M. Jones. (2019) Epidemiology of the U.S. opioid crisis: the importance of the vector. Annals of the New York Academy of Sciences 1451:1, pages 130-143.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
David P. Keseg, James J. Augustine, Raymond L. Fowler, Kenneth A. Scheppke, David A. Farcy & Paul E. Pepe. (2019) Annotated Guidance and Recommendations for the Role and Actions of Emergency Medical Services Systems in the Current Opioid and Drug-Related Epidemics. The Journal of Emergency Medicine 57:2, pages 187-194.e1.
Crossref
Crossref
Philip A. Krieter, C. Nora Chiang, Shwe Gyaw & David J. McCann. (2019) Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA‐Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device. The Journal of Clinical Pharmacology 59:8, pages 1078-1084.
Crossref
Crossref
Francis Melaragni, Carly Levy, Jennifer Pedrazzi & Merissa Andersen. (2019) Assessing pharmacists’ readiness to dispense naloxone and counsel on responding to opioid overdoses. Journal of the American Pharmacists Association 59:4, pages 550-554.e2.
Crossref
Crossref
Yanjia Cao, Kathleen Stewart, Eric Wish, Eleanor Artigiani & Marcella H. Sorg. (2019) Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire. Journal of Substance Abuse Treatment 101, pages 55-66.
Crossref
Crossref
D. Matthew Walentiny, Léa T. Moisa & Patrick M. Beardsley. (2019) Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice. Neuropharmacology 150, pages 210-216.
Crossref
Crossref
Jennifer Anne Greene, Brent J Deveau, Justine S Dol & Michael B Butler. (2019) Incidence of mortality due to rebound toxicity after ‘treat and release’ practices in prehospital opioid overdose care: a systematic review. Emergency Medicine Journal 36:4, pages 219-224.
Crossref
Crossref
Jeffrey Fudin, Amelia L Persico, Jeffrey J Bettinger & Erica L Wegrzyn. (2019) The state of naloxone: Access amid a public health crisis. Medicine Access @ Point of Care 3, pages 239920261984763.
Crossref
Crossref
Brian M. Clemency, William Eggleston, Evan W. Shaw, Michael Cheung, Nicholas S. Pokoj, Michael A. Manka, Donald J. Giordano, Laura Serafin, Han Yu, Heather A. Lindstrom & David Hostler. (2019) Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study. Academic Emergency Medicine 26:1, pages 7-15.
Crossref
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud, Sana Sharma, Evan Verplancken & Christopher P. Holstege. (2018) Trends and characteristics of naloxone therapy reported to US poison centers. Addiction 113:12, pages 2309-2315.
Crossref
Crossref
Anjali Dhanda, Stephen S. O'Connor, Heather McGuire, Ellen Knox & Erika Ruth. (2018) Patterns of opioid use during initial buprenorphine/naloxone treatment in relation to changes in opioid management laws in Kentucky. The American Journal on Addictions 27:7, pages 560-566.
Crossref
Crossref
Laura C. Palombi, Catherine A. St Hill, Martin S. Lipsky, Michael T. Swanoski & M. Nawal Lutfiyya. (2018) A scoping review of opioid misuse in the rural United States. Annals of Epidemiology 28:9, pages 641-652.
Crossref
Crossref
Rebecca E. Cash, Jeremiah Kinsman, Remle P. Crowe, Madison K. Rivard, Mark Faul & Ashish R. Panchal. (2018) Naloxone Administration Frequency During Emergency Medical Service Events — United States, 2012–2016. MMWR. Morbidity and Mortality Weekly Report 67:31, pages 850-853.
Crossref
Crossref
John Howard & Jennifer Hornsby-Myers. (2018) Fentanyls and the safety of first responders: Science and recommendations. American Journal of Industrial Medicine 61:8, pages 633-639.
Crossref
Crossref
Shawn A Ryan & Robert B Dunne. (2018) Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain Management 8:3, pages 231-245.
Crossref
Crossref
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances
3
49
.
Patrick M. Beardsley & Yan Zhang. 2018. New Psychoactive Substances. New Psychoactive Substances
353
381
.